Purity you can defend to a client.
Independent HPLC + mass-spec assay on every lot; COA downloadable before you order.
≥98% HPLC · MS-confirmed
Learn more Peptide science for every animal
The serious science of peptides.
The gentle name your patients deserve.
Petides™ brings evidence-graded peptide therapeutics to veterinary medicine — for dogs, cats, horses, and the species that don't fit the textbook. Every product is third-party assayed. Every claim is tied to a real study.
Batch purity ≥98% (HPLC) Active global trials tracked: live COA on every order
HPLC ≥ 98.4% · MS-confirmed · LOT #PT-0626-A · COA ✓
Third-party tested
COA per batch
Veterinarian-formulated protocols
Transparent sourcing
Evidence-graded library
Why vets choose Petides
A science partner, not a supplement store.
We built Petides™ for the veterinarian who reads the methods section. Everything here is meant to make a peptide recommendation you can stand behind — to your client, your board, and yourself.
Evidence, graded honestly.
Every peptide is labeled Standard-of-care, In clinical trials, or Investigational — and linked to the actual papers.
3-tier grading rubric
Learn more Protocols, not guesswork.
Species- and weight-based starting protocols built with our veterinary advisors, with monitoring notes.
Patient Protocol Builder
Learn more Ordering that respects your day.
Net terms, one-click reorder, clinic-level dashboards, and pricing that protects your margin.
Net-30 · 1-click reorder
Learn more By species
More than dogs and cats.
Peptide research is moving across the animal kingdom. We organize it the way a clinic does — by the patient in front of you.
The Evidence Spine
We don't ask you to take our word for it.
Every claim links to a real study, tagged by tier. Browse the full library, filter by species and indication, and see what's recruiting near you.
In clinical trialsOKAVA · USA · Cats · Recruiting
MEOW-1 (OKV-119)
First GLP-1 weight-loss trial in cats — ultra-long-acting exenatide implant, up to 6 months from one dose.
Standard-of-careEstablished · Dogs
Desmopressin (DDAVP)
Transiently raises vWF and shortens bleeding time in von Willebrand's disease — enabling surgery.
Standard-of-careVeterinary World · Brazil · Dogs & Cats
NT-proBNP biomarker
Validated cardiac biomarker for diagnosing and monitoring congestive heart failure.
InvestigationalEquine tendon/ligament · Multi-country
TB-500 / Tβ4 fragment
Drives actin binding, cell migration, and angiogenesis. Banned in many racing jurisdictions — verify.
Featured peptide categories
Browse the library, the way you'd reach for a reference shelf.
Tissue & wound repair
Actin-binding & angiogenic peptides accelerating dermal and tendon healing.
Examples
Tβ4 fragment (TB-500), BPC-157
Metabolic & weight (GLP-1 era)
GLP-1 receptor agonists modulating appetite and glucose homeostasis.
Examples
Exenatide implant (OKV-119)
Gut & GI
Mucosal-trophic peptides supporting GI protection and repair signals.
Examples
BPC-157 (rodent model evidence)
Immune & senior support
Thymic peptides exploring immune modulation in aging and oncology.
Examples
Thymosin α-1
Joint, tendon & ligament
Regenerative signaling for connective tissue in working and sport animals.
Examples
Tβ4 fragment — equine practice
Diagnostic & endocrine
Peptide hormones and analogs central to everyday veterinary practice.
Examples
Insulin, DDAVP, GnRH, NT-proBNP
From the field
Quiet trust, built one clinic at a time.
"
The COA-before-order workflow is what got us off the fence. I can show clients exactly what's in the vial.
"
Honest evidence tiers. When something is investigational, they say so. That's rarer than it should be.
"
The Protocol Builder cut my chart-prep for peptide cases in half.
By the numbers
1,240+
Clinics in waitlist
8,900+
Patients supported
37
Active trials tracked
≥98.4%
Median lot purity (HPLC)
Case study teaser: A 14-year-old Thoroughbred with chronic superficial digital flexor tendon lesion — 12-week ultrasound-monitored protocol.
Read the case studiesFor veterinarians
Open your veterinary account in under 5 minutes.
COA access, locked dosing protocols, the Patient Protocol Builder, and net-terms pricing unlock on approval. Reviewed within 1 business day.